ecancer
ecancer is a UK charity which provides accessible, high-quality educational content, free to the global oncology community. Our mission is to raise the standards of care for cancer patients across the world through education.
2020 ESMO Update on Advanced Melanoma: Does Lenvatinib/Pembrolizumab Combination Have Activity in Patients With Confirmed Progression on a PD-1/L1 Inhibitor?
By
ecancer
FEATURING
Ana Arance
By
ecancer
FEATURING
Ana Arance
Comments 0
Login to view comments.
Click here to Login
